Annual Meetings

RADARS System 17th Annual Scientific Virtual Meeting Wednesday May 10, 2023

Agenda

Surveillance of Psychoactive Drugs: Opioids, Psychedelics, and Cannabinoids

- Richard C. Dart, MD, PhD, Executive Director RADARS System

Application of Systems Science in Opioid Misuse to Psychedelic Drugs

- Mohammad S. Jalali, PhD

Cannabis: Lessons Learned from the Public Experience in Colorado

- Mike Van Dyke, PhD, CIH

Policy Suggestions to Support the Safe Uses of Psychedelics

- Brian Anderson, MD, MSC

Assessing Polysubstance Use of Licit (Gabapentin, Xylazine) and Illicit Substances

- Sandra Comer, PhD

Defining Polysubstance Use in a National Population-based Survey

- Karilynn Rockhill, MPH

Satisfying the Craving for Novel Psychoactive Post-Market Surveillance

- Andrew Monte, MD, PhD

RADARS System 16th Annual Scientific Virtual Meeting Tuesday May 17, 2022

Agenda

Evolving Safety of Psychoactive Drugs

- Richard C. Dart, MD, PhD, Executive Director RADARS System

Heterogeneous Patterns of Stimulant Initiation: A Study of Typologies

- Joshua C. Black, PhD Senior Research Scientist

Does Over-the-Counter Mean Under the Radar?

- Stefania Chiappini, MD

Abuse Trends In Over-The-Counter Medications

- Jennifer Jewell, DrPH

Am I Dreaming? The Misuse and Abuse of Psychedelics - A Mosaic Perspective of Psychedelics Landscape

- Marta Sokolowska, PhD

Psychedelics in the Real World: Using Real World Evidence to Prepare for Approval

- Janetta L. Iwanicki, MD

Fake Drugs, Real Risk: Answered and Unanswered Questions about Counterfeit Drugs: Targeted Literature Review

- Joshua C. Black, PhD

RADARS System 15th Annual Scientific Meeting May 13, 2021

Agenda

Postmarketing Surveillance: What’s the Next Move?

- Richard C. Dart, MD, PhD

Meeting the Challenges of COVID-19 in Postmarketing Surveillance

- Janetta L. Iwanicki, MD

Defining Populations of Interest for Post-Marketing Studies

- Nabarun Dasgupta, MPH, PhD

Prescribing and Over-The-Counter Drugs; A Vast Range of Misusing Opportunities

- Professor Fabrizio Schifano

Understanding Stimulant Use in the General Population: Prevalence and Patterns of Non-Medical Use

- Joshua C. Black, PhD

It’s not Easy Being Buprenorphine: Identifying Unique Substance Use Patterns Associated with Buprenorphine

- Matthew Ellis, MPE, PhD(c)

FDA’s Holistic Approach to Addressing Polysubstance Use and the Drug Overdose Crisis

- Marta Sokolowska, PhD

RADARS System 14th Annual Scientific Meeting May 12, 2020

Agenda

A New Frontier: Prescription Drug Abuse Beyond Opioids

- Richard C. Dart, MD, Ph.D., Executive Director RADARS System

Drug overdose statistics from the National Vital Statistics System

- Margaret Warner, PhD

One Drug? Two Drugs? Polydrug Mortality Is More Common Than We Think

- Joshua C. Black, Ph.D.

Key Priorities for FDA’s Controlled Substances Program

- Marta Sokolowska, PhD

Pharmacoepidemiologic Research on Drugs of Abuse

- Judy A. Staffa, Ph.D., R.Ph.

How Low Can You Go: Solving the Challenge of Low Volume Endorsements in the General Population

- Joshua C. Black, Ph.D.

RADARS System 13th Annual Scientific Meeting and International Pre-Symposium
May 15-16, 2019

Agenda Speakers List

International Pre-Symposium:
Canada and the Global Mosaic: How Does Prescription Drug Abuse Compare?

- Janetta L. Iwanicki, MD

International Pre-Symposium:
Canadian Approach to Prescription Opioid Risk Management

- Andrew Slot, PhD

International Pre-Symposium:
Codeine in Canada – Don’t Forget Weak Opioids…

- Beth Sproule, RPh, BScPhm, PharmD

International Pre-Symposium:
Emerging Changes in Opioid Diversion in Canada and the United States

- Mance E. Buttram, PhD & Steven P. Kurtz, PhD

International Pre-Symposium:
Who’s Winning? Opioid Abuse Patterns in the United States and Canada

- Theodore J. Cicero, PhD

Annual Meeting:
Welcome and RADARS® System 2018 Data Updates

- Richard C. Dart, MD, PhD

Annual Meeting:
Project Lazarus: Local Solutions to National Opioid Crisis; What They Need to Know

- Fred Wells Brason II, Chaplain

Annual Meeting:
The Epidemiology of Prescription Opioid Abuse: A Regulatory Perspective

- Gerald J. Dal Pan, MD, MHS

Annual Meeting:
Mortality Involving Prescription Drugs

- Joshua C. Black, PhD

Annual Meeting:
Lessons from Opana® ER: Policy, Behavior, and Reality

- Janetta L. Iwanicki, MD

Annual Meeting:
The Route to Utilization of Trend-in-Trend

- John Schwarz, PhD

Annual Meeting:
Comment: Using Trend-in-Trend to Evaluate Drug Abuse

- Rose Radin, PhD, MPH

Annual Meeting:
Drug Diversion in Healthcare Facilities: Our Nation’s Little Secret

- John J. Burke

RADARS System 12th Annual Scientific Meeting and International Pre-Symposium
May 9-10, 2018

Agenda Speakers List

International Pre-Symposium:
The Global Mosaic: Is Prescription Drug Misuse Really Different Among Countries?

- Janetta Iwanicki, MD

International Pre-Symposium:
The Growing Nexus Between NARCOS and Counterfeit Medicines

- J. Aaron Graham & John J. Burke

International Pre-Symposium:
Acute Harms of Prescription Drug Misuse: What Can We Learn from the European Drug Emergencies Network (Euro-DEN) Plus Project

- David Wood, MD, FRCP, FACMT, FBPhS, FEAPCCT

International Pre-Symposium
Understanding the Evolution of the Opioid Epidemic in Canada, and the Risks of Poly-Substance Use

- Tara Gomes, PhD

Annual Meeting:
Welcome and RADARS System 2017 Data Updates

- Richard C. Dart, MD, PhD

Annual Meeting:
Effectiveness of ADFs in the Real World

- Richard C. Dart, MD, PhD

Annual Meeting:
Understanding Changes in the US ‘Heroin’ Market: Notes from the Field

- Dan Ciccarone, MD, MPH

Annual Meeting:
The Illicit Injection of Prescription Opioids in Scott County, Indiana: Risks and Rewards

- Jon E. Zibbell, PhD

Annual Meeting:
FDA’s Current Approach to the Postmarket Evaluation of Opioid Analgesic Products with Properties Intended to Deter Abuse

- Tamra E. Meyer, PhD, MPH

Annual Meeting:
Thinking Outside the Opioid Box: Non-Opioid Pharmaceutical Abuse

- Janetta L. Iwanicki, MD

RADARS System 11th Annual Scientific Meeting and International Pre-Symposium
May 11-12, 2017

Agenda

International Pre-Symposium: Global Insights in Prescription Drug Misuse

- Jody L. Green, PhD, CCRP

International Pre-Symposium: Opioid Surveillance and Policy Evaluation: A Canadian Perspective

- Tara Gomes

International Pre-Symposium: Comparative Assessments of the Prescription Drug Abuse Climate in Europe and the United States

- Scott P. Novak, PhD

International Pre-Symposium: Cross-Border Trafficking of Prescription Oxycodone Products Manufactured in Canada

- Richard C. Dart, MD, PhD

Annual Meeting Welcome and RADARS System 2016 Data Updates

- Richard C. Dart, MD, PhD

Annual Meeting: Behind the Opioid Epidemic – Fentanyl, Immediate Release Opioids, and Mortality

- Janetta L. Iwanicki, MD

Annual Meeting: Darknet Drug Markets

- Michael Gilbert, MPH and Nabarun Dasgupta, MPH, PhD

Annual Meeting: Abuse Deterrent Formulations of Opioids

- Richard Chapman, PhD, MS

Annual Meeting: Evaluating the Impact of Abuse Deterrent Formulations

- Judy A. Staffa, PhD, RPh

Annual Meeting: Abuse Deterrent (Tamper Resistant) Formulations State of the Evidence 2017

- Richard C. Dart, MD, PhD

Annual Meeting: RAPID Analysis of Routes of Administration

- Theodore J. Cicero, PhD

RADARS System 10th Annual Scientific Meeting and International Pre-Symposium May 5-6, 2016

Agenda

International Pre-Symposium:
Prescription Drug Misuse – A Global Crisis?

- Jody L. Green, PhD, CCRP

International Pre-Symposium:
Non-Prescription Fentanyl: Canadian Fentanyl Trends Moving to the US

- Steven P. Kurtz, PhD

International Pre-Symposium:
Misuse of Medications in the UK and Related Advisory Council on Misuse of Drugs (ACMD) Activities

- Professor Raymond G. Hill, BPharm, PhD, DSc (Hon), FMedSci

International Pre-Symposium:
Trends of Prescription Drug Misuse in the UK and Singapore

- David Wood, MD, FRCP, FEAPCCT, FACMT, FBPhS

Annual Meeting:
Welcome and RADARS® System 2015 Data Updates

- Richard C. Dart, MD, PhD

Annual Meeting:
Prescription Opioid and Heroin Abuse in the United States

- Christopher M. Jones, PharmD, MPH

Annual Meeting:
Setting the Stage: Are Abuse Deterrent Formulations Ready for Prime Time?

- Lewis S. Nelson, MD

Annual Meeting:
NSDUH Trends in Nonmedical Use of Prescription Opioids

- Scott P. Novak, PhD

Annual Meeting:
Abuse Deterrent Opioids: Lessons for the “Downward Spiral”

- Richard C. Dart, MD, PhD

Annual Meeting:
The Political Factors Affecting the Abuse Deterrent Formulations

- Dan Cohen, MALS

Annual Meeting:
Drug Diversion Investigators

- John J. Burke

Annual Meeting:
Street Prices

- Nabarun Dasgupta, MPH, PhD

Annual Meeting:
Patients Entering Substance Abuse Treatment

- Theodore J. Cicero, PhD

Annual Meetings

Registration is now open